| Literature DB >> 29944852 |
Adriana Schapochnik1, Marcia Rodrigues da Silva1, Mayara Peres Leal1, Janete Esteves1, Cristina Bichels Hebeda2, Silvana Sandri2, Daniela de Fátima Teixeira da Silva1, Sandra Helena Poliseli Farsky2, Rodrigo Labat Marcos1, Adriana Lino-Dos-Santos-Franco3.
Abstract
A high incidence of intentional or accidental paraquat (PQ) ingestion is related to irreversible lung fibrosis and no effective therapy is currently available. Vitamin D has emerged with promising results as an immunomodulatory molecule when abrogating the inflammatory responses of lung diseases. Therefore, we have investigated the role of vitamin D treatments on PQ-induced lung fibrosis in male C57/BL6 mice. Lung fibrosis was induced by a single injection of PQ (10 mg/kg; i.p.). The control group received PQ vehicle. Seven days later, after the PQ injection or the vehicle injection, the mice received vitamin D (5 μg/kg, i.p., once a day) or vehicle, for a further 7 days. Twenty-four hours after the last dose of vitamin D or the vehicle, the analysis were performed. The vitamin D treatments reduced the number of leukocytes in their BALF and they decreased the IL-6, IL-17, TGF-beta and MMP-9 levels and the abrogated collagenase deposits in their lung tissues. Conversely, the vitamin D treatments increased the resolvin D levels in their BALF. Moreover, their tracheal contractility was also significantly reduced by the vitamin D treatments. Altogether, the data that was obtained showed a promising use of vitamin D, in treating the lung fibrosis that had been induced by the PQ intoxications. This may improve its prognostic use for a non-invasive and low cost therapy.Entities:
Keywords: Collagen Production; Cytokines; Lung fibrosis; Metalloproteinases; Paraquat intoxication; Tracheal responsiveness
Mesh:
Substances:
Year: 2018 PMID: 29944852 DOI: 10.1016/j.taap.2018.06.020
Source DB: PubMed Journal: Toxicol Appl Pharmacol ISSN: 0041-008X Impact factor: 4.219